Joined April 2013
- Tweets 1,376
- Following 565
- Followers 710
- Likes 162
880 Photos and videos
Jun 12
Manual listing review doesn't scale without sacrificing quality. Traditional approaches deliver only 40% precision—creating bottlenecks and wasted DM capacity on false positives. There has to be a better way.
Read the full story: hubs.ly/Q04kWpB60
4
Jun 2
Clinical trials are rebounding. Scaling them without compromising quality is the real challenge.
Pat Hughes shares 3 trends shaping the future of clinical development.
hubs.ly/Q04jM3sZ0
#ClinicalTrials #RBQM #AI
25
May 29
Wrapping up a fantastic time at the Veeva R&D and Quality Summit in Copenhagen! 🇩🇰 Huge thanks to Andrew Taylor, Paul MacDonald, Charlotte Byng, and Matthew Davies for representing CluePoints. Great conversations, meaningful connections, and one very lucky Meta AI glasses winner!
27
May 29
Wrapping up a fantastic time at the Veeva R&D and Quality Summit in Copenhagen! 🇩🇰 Huge thanks to Andrew Taylor, Paul MacDonald, Charlotte Byng, and Matthew Davies for representing CluePoints. Great conversations, meaningful connections, and one very lucky Meta AI glasses winner!
21
May 26
Clinical trials stuck in legacy mode? AI advanced stats can transform data management—80% precision in listing review, 99% accuracy in medical coding. Time to keep research rising. 🚀 #ClinicalTrials #AI
18
May 19
Safety oversight isn't just detection, it's connection. Our analysis of 2,000 clinical studies reveals the power of linking risk assessment, monitoring, triage, and action into one integrated system. Read the full insights: hubs.ly/Q04h5FpJ0
4
May 5
CluePoints is at #SCMDEMEA! 🎙️
Join Sas Maheswaran & Sarah Gill on May 6th (10:30am) for: Unlocking Scientific Robustness and Operational Efficiency with RBQM.
Be sure to stop in and listen. You won't want to miss it.
17
Apr 22
The same rigor we bring to clinical trial data, we bring to our own footprint. At CluePoints, sustainability means dedicated teams, measurable goals, and real accountability — for healthier trials and a healthier planet. hubs.ly/Q04d2wY40
17
Apr 16
AI is no longer experimental in clinical trials. It’s operational.
At PCMG Annual Assembly 2026, Richard Young will explore the five defining questions every organization must answer before embedding AI into clinical workflows.
📅 June 16 | 11:30–12:15 CEST | Berlin
18
Apr 15
AI in clinical trials is well established. But are we applying it just as smartly to the people who run them?
The future of clinical data recruitment isn't automated — it's augmented.
👉 hubs.ly/Q04c89cb0
14
Mar 31
Mid-market clinical teams: RBQM doesn't have to be complicated.
Our new guide gives you a practical, audit-ready framework — without the enterprise overhead.
Read the guide → hubs.ly/Q048XKHF0
16
Mar 25
Still treating RBQM as a checkbox exercise?
Join us April 22-23 in DC for:
✨ AI & agentic workflow keynotes
✨ Practical RBQM strategies
✨ 30% efficiency gains you can implement immediately
Register: hubs.ly/Q048k3Wr0
15
Mar 23
Agentic AI is creating real buzz in clinical trials, but will it deliver?
In areas like medical coding and data management, it could boost productivity by up to 60%. And as Usama says, agentic AI isn’t a replacement for human expertise, t’s an amplifier. hubs.ly/Q047Xs330
23
Mar 19
Everyone understands RBQM in theory. Far fewer actually do it.
Still reducing RBQM to KRI lists and SDV reductions?
ICH E6(R3) moved the goalposts.
We updated our Ultimate Guide for ICH E6(R3). Practical, not theoretical.
hubs.ly/Q047zh0C0
48
Mar 16
CluePoints is onsite at #ACDM26 in Berlin! Sas Maheswaran presented earlier on LLM-driven scenario analysis. If you missed it, visit Booth 40. Later today: Marta Kowalska (CluePoints) & Jennifer Nielsen (Lundbeck) will be speaking on “Getting Started with RBQM/ATR” at 5:45PM.
30
Mar 12
Informed consent under ICH E6(R3) is no longer just a signature on a form.
It's a continuous, participant-centered process — with real implications for sponsors and CROs.
Part 4 of our ICH E6(R3) Demystified series is now live 👇
hubs.ly/Q046x7Pq0
13
Mar 9
Investing in women isn't a subtraction — it's an intentional multiplication. 🌱
Our CPO Sinead Godkin shares her perspective on pay-it-forward leadership this #IWD2026 in @pharmaphorum:
hubs.ly/Q0462NKl0
#WhenWomenThrive #WomeninSTEM #CluePoints
13
Mar 4
Join Marta Kowalska (CluePoints) & Jennifer Neilson (Lundbeck) on March 16, 5:45–6:15 PM for Getting Started with RBQM / ATR — and see how smarter oversight drives inspection readiness and stronger data quality.
👉 Secure your place here: hubs.ly/Q045xZrG0
18
Feb 24
Tools don’t transform trials. People do.
On March 15 (5:15–6:45pm) at #ACDM26 in Berlin, Tessa Barrett (CluePoints) joins the “Bridging the Behaviour Gap” workshop to explore how teams adapt and how real change happens in clinical data management.
Join us: hubs.ly/Q044dN9s0
24
Feb 23
Snow day reading? ❄️
Part 3 of our #ICHE6R3 series breaks down Quality Tolerance Limits (QTLs) — and why they’re central to proactive, risk-based oversight.
Defining QTLs is easy. Monitoring them intelligently is the real shift.
🔗 hubs.ly/Q044cPR20
20